The technical field to which this invention relates is orthopedic implants, in particular, orthopedic implants useful for anterior cruciate ligament repair procedures.
The anterior cruciate ligament (ACL) is a major component of the soft tissue in a human knee that is responsible for stability of the knee. In addition to the ACL, several other ligaments provide stability including the posterior cruciate ligament (PCL) and the medial and lateral collateral ligaments (MCL/LCL). It is not uncommon for a person to rupture or tear the ACL during various types of physical activities including sports, work, and the like. The tear or rupture can be caused by trauma such as impact, or by abrupt stopping or turning movements which cause exceptional forces to be transmitted to the ACL. Typically a torn or ruptured ACL cannot be repaired using conventional soft tissue repair procedures such as suturing, stapling, etc. It is necessary to replace the ACL with a graft. The graft may be an autograph harvested, for example, from the patient's patellar tendon or hamstring tendon, an allograft harvested from a cadaver, a xenograft, or an artificial man-made tendon. Tissue-engineered ligaments may also be available. In a typical ACL reconstruction, axial tunnels are drilled into the patient's tibia and femur by the surgeon using conventional surgical drills, drill guides and instruments. Once the knee is prepared, the graft is then inserted by the surgeon into the tibial and femoral tunnels, such that one end of the graft resides in each tunnel. The graft is adjusted by the surgeon to provide the desired range of motion. Finally, the graft is secured at both ends in a conventional manner to complete the ACL repair or reconstruction. For example, the graft ends may be secured with conventional interference screws, etc. An alternate method of securement is to use a cross-pin, in particular a femoral cross-pin. In this type of procedure, a transverse hole is drilled into the end of femur such that it intersects the femoral tunnel, and a guide wire is threaded through the transverse tunnel. A cannulated cross-pin is then inserted into the transverse tunnel over the guide wire and underneath a looped end of the graft in order to secure the graft in the femoral tunnel. The guide wire is then removed. If desired, the other end of the graft may be secured in the tibial tunnel by a tibial cross-pin in a similar manner.
Although the cannulated cross-pins known in this art are sufficient and adequate for their intended purposes, there is a continuing need in this art for improved cross-pins and surgical techniques. For example, there is a need for novel cross-pins that provide uni-cortical fixation and intraoperative removal or revision, eliminate or reduce the need for multiple size (length) implants, and simplify the need to make measurements and calculations in order to determine appropriate length.
Accordingly, there is a need in this art for novel cannulated cross-pins for use in ACL reconstruction procedures.
A novel cross-pin for use in ACL reconstruction procedures is disclosed. The cross-pin has an elongated member having a proximal end, a distal end, an outer surface, and a longitudinal axis. A nose member extends out from the distal end. The nose member has a proximal end and a distal end. There is an axial trough in the member extending through the outer surface. The trough has a proximal end, a distal end, a bottom, an open top and a passageway. There is a guide-wire opening in the distal end of the nose member. There is also an interior passage in the nose member that extends from the guide-wire opening through to the trough such that the passage is in communication with the guide wire opening and the trough.
Another aspect of the present invention is a method of securing the end of an ACL ligament implant in a bone tunnel using the above-described implantable cross-pin.
These and other aspects and characteristics of the present invention will become more apparent from the following description and accompanying drawings.
The cross-pins of the present invention can be made from a variety of conventional biocompatible materials useful in implants. The materials may be absorbable or non-absorbable. Examples of conventional non-absorbable materials include surgical stainless steel, nickel titanium alloys, ceramics, Delrin, polyethylene, and other non-absorbable polymers including, but not limited to, polypropylene, and Acetal. Examples of bioabsorbable materials include PLA, PGA, polydioxanone, polycaprolactone, copolymers thereof, and the like. The term “natural polymer” refers to polymers that are naturally occurring, as opposed to synthetic polymers. In embodiments where the device includes at least one synthetic polymer, suitable biocompatible synthetic polymers can include polymers selected from the group consisting of aliphatic polyesters, poly(amino acids), copoly(etheresters), polyalkylenes oxalaes, polyamides, tyrosine derived polycarbonates, poly(iminocarbonates), polyorthoesters, polyoxaesters, polyamidoesters, polyoxaesters containing amine groups, poly(anhydrides), polyphosphazenes, polyurethanes, poly(ether urethanes), poly(ester urethane) and blends thereof. Suitable synthetic polymers for use in the present invention can also include biosynthetic polymers based on sequences found in collagen, elastin, thrombin, fibronectin, starches, poly(amino acid), poly(ptopylene fumarate), geletin, alginate, pectin, fibrin, oxidized cellulose, chitin, chitosan, tropoelastin, hyaluronic acid, ribonucleic acids, deoxyribonucleic acids, polypeptides, proteins, polysaccharides, polynucleotides and combination thereof. The devices of the present invention may also be manufactured from conventional biocompatible natural polymers. If desired, the bioabsorbable materials way contain osteoinductive or osteoconductive materials, polymers and blends of polymers including but not limited to calcium hydroxyapatite, tricalcium phosphate, and the like.
The cross-pins of the present invention may be made using a variety of conventional manufacturing processes including machining, molding, etc., and combinations thereof.
As seen in
The cross-pin of the present is used in combination with a conventional guide wire in order to secure an ACL replacement ligament graft into a femoral tunnel. A variety of methods of securing ACL replacement ligament grafts in femoral tunnels using conventional cannulated cross-pins are known in the art. For example U.S. patent application Ser. No. 10/439,752, which is incorporated by reference, discloses a method of moving an ACL graft into a femoral tunnel and securing it with a cannulated cross-pin moved over a guide wire.
A method of using the novel cross-pins of the present invention to secure the end of a graft in a bone tunnel is now described. Referring to now to
The novel method and cross-pin 5 of the present invention have many advantages. The advantages include the ability to remove pin at time of surgery, and, no uni-cortical fixation (equal distribution of load across the device). In addition the pin is centered in the femoral tunnel and a single size implant may be used.
Although this invention has been shown and described with respect to detailed embodiments thereof, it will be understood by those skilled in the art that various changes in form and detail thereof may be made without departing from the spirit and scope of the claimed invention.
This application is a divisional application of U.S. patent application Ser. No. 10/808,764, entitled IMPLANTABLE CROSS-PIN FOR ANTERIOR CRUCIATE LIGAMENT REPAIR, filed Mar. 25, 2004, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4968315 | Gatturna | Nov 1990 | A |
5098435 | Stednitz et al. | Mar 1992 | A |
5102421 | Anspach, Jr. | Apr 1992 | A |
5211647 | Schmieding | May 1993 | A |
5257996 | McGuire | Nov 1993 | A |
5269809 | Hayhurst | Dec 1993 | A |
5474554 | Ku | Dec 1995 | A |
5480403 | Lee | Jan 1996 | A |
5702397 | Goble | Dec 1997 | A |
5733307 | Dinsdale | Mar 1998 | A |
5849013 | Whittaker | Dec 1998 | A |
5885294 | Pedlick | Mar 1999 | A |
5993459 | Larsen | Nov 1999 | A |
6113604 | Whittaker | Sep 2000 | A |
6132433 | Whelan | Oct 2000 | A |
6306138 | Clark | Oct 2001 | B1 |
6499486 | Chervitz et al. | Dec 2002 | B1 |
6508830 | Steiner | Jan 2003 | B2 |
6540783 | Whittaker | Apr 2003 | B1 |
6579295 | Supinski | Jun 2003 | B1 |
6623524 | Schmieding | Sep 2003 | B2 |
7032599 | May | Apr 2006 | B2 |
7338492 | Singhatat | Mar 2008 | B2 |
8088128 | May | Jan 2012 | B2 |
20020019635 | Wenstrom | Feb 2002 | A1 |
20020058941 | Clark | May 2002 | A1 |
20020087160 | Clark | Jul 2002 | A1 |
20020133165 | Whittaker | Sep 2002 | A1 |
20020156484 | McKernan | Oct 2002 | A1 |
20030009217 | McKernan | Jan 2003 | A1 |
20030130666 | Whittaker | Jul 2003 | A1 |
20040133239 | Singhatat | Jul 2004 | A1 |
20050033301 | Lombardo | Feb 2005 | A1 |
20050159812 | Dinger | Jul 2005 | A1 |
Number | Date | Country |
---|---|---|
0829233 | Mar 1998 | EP |
Entry |
---|
EP Search Report dated Jan. 27, 2006 for EP Application No. 05251849.5. |
Number | Date | Country | |
---|---|---|---|
20120071976 A1 | Mar 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10808764 | Mar 2004 | US |
Child | 13301975 | US |